Stephane Birkle

City:

Nantes

Country:

France

Published Applications:

Last publication date:

2024-07-11

Top Assignees for applications by Stephane Birkle

The entities that hold a legal rights for patent applications filed by inventor Birkle Stephane:

UNIVERSITE DE NANTES 5 Nantes, France
OGD2 PHARMA 5 Nantes, France
NANTES UNIVERSITÉ 3 Nantes, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 2 Paris, France
INSTITUT DE RADIOPROTECTION ET DE SURETE NUCLEAIRE 1 Fontenay-Aux-Roses, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 1 Paris, France
Centre National de la Recherche Scientifique (CNRS 1 Paris, France
INSTITUT DE CANCEROLOGIE DE L'OUEST 1 Angers, France

Recent patent applications by Birkle Stephane

Stephane Birkle from Nantes, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-07-11

US20240228659A1

Chemistry; metallurgy

NEW METHOD TO IMPROVE NK CELLS CYTOTOXICITY

#2 | 2024-06-13

US20240190993A1

Chemistry; metallurgy

NEW METHOD TO IMPROVE THE ANTI-TUMORAL ACTIVITY OF MACROPHAGES

#3 | 2023-12-28

US20230416398A1

Chemistry; metallurgy

USE OF ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE TO IMPROVE THE THERAPEUTIC POTENTIAL OF DRUGS

#4 | 2019-12-12

US20190375853A1

Chemistry; metallurgy

Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs

#5 | 2019-01-24

US20190023808A1

Chemistry; metallurgy

Targeting o-acetylated gd2 ganglioside as a new therapeutic and diagnostic strategy for cancer

#6 | 2016-03-10

US20160068608A1

Chemistry; metallurgy

Targeting O-acetylated GD2 ganglioside as a new therapeutic and diagnostic strategy for cancer stem cells cancer

#7 | 2015-05-21

US20150140023A1

Human necessities

Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for the treatment of certain cancers

#8 | 2014-02-13

US20140044721A1

Chemistry; metallurgy

ANTI-GB3 ANTIBODIES USEFUL IN TREATING DISORDERS ASSOCIATED WITH ANGIOGENESIS

#9 | 2010-06-17

US20100150910A1

Chemistry; metallurgy

Use of monoclonal antibodies specific to the O-acetylated form of GD2 ganglioside for treatment of certain cancers

InventorID:

649869 ⎘